Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 07:31 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot Study
NCT00493428 · University of Manitoba · PHASE2 · withdrawn · last registry update 2014-05-16 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “The study have been stoped because the protocol is going to be modify.” | – | Registry record, University of Manitoba |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against GABBR1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2015-03-06Also stopped (withdrawn): Flowonix Medical, a drug against GABBR1 (NCT01051128)
- 2015-02-05Results posted on the registry: University of Virginia, Baclofen (NCT02298868)
- 2014-08-21Phase 3 first posted: Jazz Pharmaceuticals, Xyrem (NCT02221869)
- 2014-03-31Results posted on the registry: University of Utah, Sodium Oxybate (NCT00931164)
- 2014-03-28Phase 3 first posted: University of Rochester, Amitriptyline + Baclofen (NCT02099006)
- 2014-02-03Phase 3 first posted: Denver Health and Hospital Authority, Baclofen + Placebo (NCT02052440)
- 2013-11-25Results posted on the registry: Jazz Pharmaceuticals, Xyrem (sodium oxybate) oral solution (NCT00132873)
- 2013-10-17Results posted on the registry: Brown University, Baclofen + Cyproheptadine (NCT01076283)
- 2013-09-12Also stopped (terminated): Centre for Addiction and Mental Health, Baclofen 30 mg/day + placebo pill (NCT01228994)
- 2013-07-31Also stopped (terminated): Seaside Therapeutics, Inc., STX209 (arbaclofen) (NCT01706523)
- 2013-07-31Also stopped (terminated): Seaside Therapeutics, Inc., arbaclofen (NCT01555333)
- 2013-06-14Results posted on the registry: Seaside Therapeutics, Inc., Arbaclofen (NCT00846547)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision